diazoxide has been researched along with Bleeding in 6 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study sought to determine whether chemical destruction of peripheral catecholaminergic fibers with 6-hydroxydopamine (6OHDA) attenuates vasopressin (VP) and oxytocin (OT) secretion stimulated by hemorrhage, hypotension, and hyperosmolality." | 7.73 | Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats. ( Lone, U; Madden, CJ; Stocker, SD; Sved, AF; Wilson, ME, 2006) |
| "The present study sought to determine whether chemical destruction of peripheral catecholaminergic fibers with 6-hydroxydopamine (6OHDA) attenuates vasopressin (VP) and oxytocin (OT) secretion stimulated by hemorrhage, hypotension, and hyperosmolality." | 3.73 | Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats. ( Lone, U; Madden, CJ; Stocker, SD; Sved, AF; Wilson, ME, 2006) |
| "Background Congenital hyperinsulinism (CH) is the most frequent cause of persistent hypoglycemia in the newborn." | 1.56 | Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism. ( Argente, J; Celaya, P; Cilleruelo, ML; Golmayo, L; Güemes, M; Gutiérrez, C; Lacámara, N; Martínez-Badás, I; Ros-Pérez, P, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ros-Pérez, P | 1 |
| Golmayo, L | 1 |
| Cilleruelo, ML | 1 |
| Gutiérrez, C | 1 |
| Celaya, P | 1 |
| Lacámara, N | 1 |
| Martínez-Badás, I | 1 |
| Güemes, M | 1 |
| Argente, J | 1 |
| Stocker, SD | 1 |
| Wilson, ME | 1 |
| Madden, CJ | 1 |
| Lone, U | 1 |
| Sved, AF | 1 |
| Chang, HY | 1 |
| Chen, CW | 1 |
| Hsiue, TR | 1 |
| Chen, CR | 1 |
| Diéguez, G | 1 |
| Fernández, N | 1 |
| Sánchez, MA | 1 |
| Martínez, MA | 1 |
| García-Villalón, AL | 1 |
| Monge, L | 1 |
| Gómez, B | 1 |
| Sponer, G | 1 |
| Schelling, P | 1 |
| Ganten, D | 1 |
| Gross, F | 1 |
| Powers, JC | 1 |
| Shaftan, GW | 1 |
| Herbsman, H | 1 |
6 other studies available for diazoxide and Bleeding
| Article | Year |
|---|---|
Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism.
Topics: Congenital Hyperinsulinism; Diazoxide; Exocrine Pancreatic Insufficiency; Hemorrhage; Humans; Infant | 2020 |
Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats.
Topics: Animals; Diazoxide; Dopamine beta-Hydroxylase; Hemorrhage; Hypotension; Hypothalamus; Injections, In | 2006 |
Role of KATP channels on modulating diaphragmatic microvascular flow during hemorrhagic hypotension.
Topics: Adenosine Triphosphate; Animals; Diaphragm; Diazoxide; Glyburide; Hemorrhage; Hypotension; Laser-Dop | 1997 |
Role of nitric oxide in the cerebral circulation during hypotension after hemorrhage, ganglionic blockade and diazoxide in awake goats.
Topics: Animals; Blood Pressure; Cerebrovascular Circulation; Diazoxide; Enzyme Inhibitors; Female; Ganglion | 1999 |
Effect of beta-adrenoceptor blockade on the cardiovascular and hyperglycaemic actions of diazoxide.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Blood Glucose; Diazoxide; Drug Interactions; H | 1978 |
Evaluation of various hypotensive agents in the control of experimental hemorrhage.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Chlorpromazine; Diazoxide; Dogs; Drug Evaluation, | 1975 |